+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Next-Generation Sequencing (NGS) Market Analysis 2019

  • ID: 4857829
  • Report
  • October 2019
  • Region: Global
  • 154 pages
  • Syngene Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 10x Genomics
  • Agilent Technologies Inc
  • BGI
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Genewiz
  • MORE
The Global Next-Generation Sequencing (NGS) market is expected to reach $25.09 billion by 2026 growing at a CAGR of 20.6% from 2018 to 2026. Next-Generation Sequencing (NGS) is a technology in which millions and billions of DNA strands can be sequenced through monstrous parallelization. This technique is otherwise called as high throughput sequencing. It limits the necessity for fragment-cloning strategies utilized in Sanger sequencing of genomes. Low cost, high accuracy & speed, and exact outcomes even from low sample input are the fundamental advantages it offer’s over Sanger’s sequencing technique. It is utilized to execute different applications for example, biomarker discovery, oncology studies, personalized medicine, agricultural & animal research, and others. It has streamlined nucleotide analysis and has generally replaced conventional tools of genomics, particularly microarray efficiently. Consequently, these aforementioned factors help in expanding the market share.

Factors such as rise in technological advancements and increase in partnerships & collaborations are driving the market growth. Though, lack of skilled professionals, and ethical & legal limitations are projected to inhibit the growth of the market. Moreover, cloud computing as a potential data management service and lucrative opportunities in emerging markets may provide ample opportunities for the market growth.

By end user, academic institutes & research centers segment acquired significant growth in the market owing to the increasing number of collaborations between the market players and academic & research institutions and on the account of wide usage of these methodologies in research and Ph.D. projects, on-site bioinformatics courses, and workshops across regions, and the development of cost-efficient products and services for researchers is leading to the market growth.

The key vendors mentioned are 10x Genomics, Agilent Technologies Inc, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, BGI, Eurofins Scientific, F. Hoffmann-La Roche AG, Genewiz, Illumina Inc, Macrogen Inc, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, Perkinelmer Inc, Qiagen N.V. and Thermo Fisher Scientific Inc.

Diseases Covered:
  • Rare Disease Diagnostics
  • Cardiovascular
  • Other Diseases
Services Covered:
  • Sequencing Services
  • Animal & Plant Sequencing
  • Gene Regulation Services
  • Human Genome Sequencing Services
  • Microbial Genome - based Sequencing Services
  • Single Cell Sequencing Services
Type of Sequencings Covered:
  • CHIP Sequencing
  • De Novo Sequencing
  • Illumina Sequencing
  • Methyl Sequencing
  • Pre-Sequencing
  • RNA Sequencing
  • Targeted Sequencing & Resequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
Informatics Covered:
  • Primary and Secondary Data Analysis Tools
  • NGS Informatics Services
  • Computing
  • Storage
  • LIMS (Laboratory Information Management System)
  • Biological Interpretation and Reporting Tools
Products Covered:
  • Reagents & Consumables
  • Instruments
  • Platforms
  • Software
  • Services
Technologies Covered:
  • 454 Technology
  • DNA Nano Ball Sequencing
  • Ion Semiconductor Sequencing
  • Ion Torrent Sequencing
  • Ion Semiconductor Sequencing
  • Massively Parallel Signature Sequencing (MPSS)
  • Nanopore Sequencing
  • Pyrosequencing
  • Reversible Terminator Sequencing
  • Sequencing by Ligation (SBL)
  • Sequencing By Synthesis
  • Sequencing by Synthesis (SBS)
  • Single Molecule Real Time (SMRT) Sequencing
  • Single-Molecule Real-Time Sequencing
  • Supported Oligonucleotide Ligation and Detection (SOLiD)
Applications Covered:
  • Agrigenomics & Forensics
  • Biomarker Discovery and Cancer
  • Cardiovascular
  • Clinical Investigation
  • Consumer Genomics
  • Drug Discovery
  • Emerging Application
  • Forensics
  • Genetic Analysis
  • Hereditary Disease Detection
  • HLA Typing/Immune System Monitoring
  • Human Leukocyte Antigen (HLA) Testing
  • Infectious Disease Diagnostics
  • Life Science
  • Metagenomics, Epidemiology & Drug Development
  • Oncology
  • Pharmaceuticals
  • Precision Medicine
  • Reproductive Health
End Users Covered:
  • Academic Institutes & Research Centers
  • Agriculture and Animal Research
  • Biotech and Pharmaceutical Firms
  • Cloud Service Providers
  • Contract Research Organization (CROs)
  • Diagnostics/Infectious Diseases
  • Drug Discovery/Personalized Medicine
  • Genetic Screening
  • Government Research Institutes
  • Hospitals & Clinics
  • Pesticides
  • Reference Laboratories
  • Research Institutions
Regions Covered:
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Key Questions Answered in this Report:
  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period

*Please Note: This report will be delivered within 48 hours of ordering.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 10x Genomics
  • Agilent Technologies Inc
  • BGI
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Genewiz
  • MORE
1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Next-Generation Sequencing (NGS) Market, By Disease
5.1 Introduction
5.2 Rare Disease Diagnostics
5.3 Cardiovascular
5.4 Other Diseases

6 Global Next-Generation Sequencing (NGS) Market, By Service
6.1 Introduction
6.2 Sequencing Services
6.3 Animal & Plant Sequencing
6.4 Gene Regulation Services
6.5 Human Genome Sequencing Services
6.6 Microbial Genome - based Sequencing Services
6.7 Single Cell Sequencing Services

7 Global Next-Generation Sequencing (NGS) Market, By Type of Sequencing
7.1 Introduction
7.2 CHIP Sequencing
7.3 De Novo Sequencing
7.4 Illumina Sequencing
7.5 Methyl Sequencing
7.6 Pre-Sequencing
7.7 RNA Sequencing
7.8 Targeted Sequencing & Resequencing
7.9 Whole Exome Sequencing
7.10 Whole Genome Sequencing

8 Global Next-Generation Sequencing (NGS) Market, By Informatics
8.1 Introduction
8.2 Primary and Secondary Data Analysis Tools
8.3 NGS Informatics Services
8.4 Computing
8.5 Storage
8.6 LIMS (Laboratory Information Management System)
8.7 Biological Interpretation and Reporting Tools

9 Global Next-Generation Sequencing (NGS) Market, By Product
9.1 Introduction
9.2 Reagents & Consumables
9.3 Instruments
9.4 Platforms
9.5 Software
9.6 Services

10 Global Next-Generation Sequencing (NGS) Market, By Technology
10.1 Introduction
10.2 454 Technology
10.3 DNA Nano Ball Sequencing
10.4 Ion Semiconductor Sequencing
10.5 Ion Torrent Sequencing
10.6 Ion Semiconductor Sequencing
10.7 Massively Parallel Signature Sequencing (MPSS)
10.8 Nanopore Sequencing
10.9 Pyrosequencing
10.10 Reversible Terminator Sequencing
10.11 Sequencing by Ligation (SBL)
10.12 Sequencing By Synthesis
10.13 Sequencing by Synthesis (SBS)
10.14 Single Molecule Real Time (SMRT) Sequencing
10.15 Single-Molecule Real-Time Sequencing
10.16 Supported Oligonucleotide Ligation and Detection (SOLiD)

11 Global Next-Generation Sequencing (NGS) Market, By Application
11.1 Introduction
11.2 Agrigenomics & Forensics
11.3 Biomarker Discovery and Cancer
11.4 Cardiovascular
11.5 Clinical Investigation
11.6 Consumer Genomics
11.7 Drug Discovery
11.8 Emerging Application
11.9 Forensics
11.20 Genetic Analysis
11.21 Hereditary Disease Detection
11.22 HLA Typing/Immune System Monitoring
11.23 Human Leukocyte Antigen (HLA) Testing
11.24 Infectious Disease Diagnostics
11.25 Life Science
11.26 Metagenomics, Epidemiology & Drug Development
11.27 Oncology
11.28 Pharmaceuticals
11.29 Precision Medicine
11.30 Reproductive Health

12 Global Next-Generation Sequencing (NGS) Market, By End User
12.1 Introduction
12.2 Academic Institutes & Research Centers
12.3 Agriculture and Animal Research
12.4 Biotech and Pharmaceutical Firms
12.5 Cloud Service Providers
12.6 Contract Research Organization (CROs)
12.7 Diagnostics/Infectious Diseases
12.8 Drug Discovery/Personalized Medicine
12.9 Genetic Screening
12.20 Government Research Institutes
12.21 Hospitals & Clinics
12.22 Pesticides
12.23 Reference Laboratories
12.24 Research Institutions

13 Global Next-Generation Sequencing (NGS) Market, By Geography
13.1 Introduction
13.2 North America
13.3 Europe
13.4 Asia Pacific
13.5 South America
13.6 Middle East & Africa

14 Strategic Benchmarking

15 Vendors Landscape
15.1 10x Genomics
15.2 Agilent Technologies Inc
15.3 Beckman Coulter (A Subsidiary of Danaher)
15.4 Becton, Dickinson and Company
15.5 BGI
15.6 Eurofins Scientific
15.7 F. Hoffmann-La Roche AG
15.8 Genewiz
15.9 Illumina Inc
15.10 Macrogen Inc
15.11 Oxford Nanopore Technologies Ltd
15.12 Pacific Biosciences of California Inc
15.13 Perkinelmer Inc
15.14 Qiagen N.V.
15.15 Thermo Fisher Scientific Inc

List of Data Tables
Table 1 Global Next-Generation Sequencing (NGS) Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Next-Generation Sequencing (NGS) Market Outlook, By Disease (2016-2026) ($MN)
Table 3 Global Next-Generation Sequencing (NGS) Market Outlook, By Rare Disease Diagnostics (2016-2026) ($MN)
Table 4 Global Next-Generation Sequencing (NGS) Market Outlook, By Cardiovascular (2016-2026) ($MN)
Table 5 Global Next-Generation Sequencing (NGS) Market Outlook, By Other Diseases (2016-2026) ($MN)
Table 6 Global Next-Generation Sequencing (NGS) Market Outlook, By Service (2016-2026) ($MN)
Table 7 Global Next-Generation Sequencing (NGS) Market Outlook, By Sequencing Services (2016-2026) ($MN)
Table 8 Global Next-Generation Sequencing (NGS) Market Outlook, By Animal & Plant Sequencing (2016-2026) ($MN)
Table 9 Global Next-Generation Sequencing (NGS) Market Outlook, By Gene Regulation Services (2016-2026) ($MN)
Table 10 Global Next-Generation Sequencing (NGS) Market Outlook, By Human Genome Sequencing Services (2016-2026) ($MN)
Table 11 Global Next-Generation Sequencing (NGS) Market Outlook, By Microbial Genome - based Sequencing Services (2016-2026) ($MN)
Table 12 Global Next-Generation Sequencing (NGS) Market Outlook, By Single Cell Sequencing Services (2016-2026) ($MN)
Table 13 Global Next-Generation Sequencing (NGS) Market Outlook, By Type of Sequencing (2016-2026) ($MN)
Table 14 Global Next-Generation Sequencing (NGS) Market Outlook, By CHIP Sequencing (2016-2026) ($MN)
Table 15 Global Next-Generation Sequencing (NGS) Market Outlook, By De Novo Sequencing (2016-2026) ($MN)
Table 16 Global Next-Generation Sequencing (NGS) Market Outlook, By Illumina Sequencing (2016-2026) ($MN)
Table 17 Global Next-Generation Sequencing (NGS) Market Outlook, By Methyl Sequencing (2016-2026) ($MN)
Table 18 Global Next-Generation Sequencing (NGS) Market Outlook, By Pre-Sequencing (2016-2026) ($MN)
Table 19 Global Next-Generation Sequencing (NGS) Market Outlook, By RNA Sequencing (2016-2026) ($MN)
Table 20 Global Next-Generation Sequencing (NGS) Market Outlook, By Targeted Sequencing & Resequencing (2016-2026) ($MN)
Table 21 Global Next-Generation Sequencing (NGS) Market Outlook, By Whole Exome Sequencing (2016-2026) ($MN)
Table 22 Global Next-Generation Sequencing (NGS) Market Outlook, By Whole Genome Sequencing (2016-2026) ($MN)
Table 23 Global Next-Generation Sequencing (NGS) Market Outlook, By Informatics (2016-2026) ($MN)
Table 24 Global Next-Generation Sequencing (NGS) Market Outlook, By Primary and Secondary Data Analysis Tools (2016-2026) ($MN)
Table 25 Global Next-Generation Sequencing (NGS) Market Outlook, By NGS Informatics Services (2016-2026) ($MN)
Table 26 Global Next-Generation Sequencing (NGS) Market Outlook, By Computing (2016-2026) ($MN)
Table 27 Global Next-Generation Sequencing (NGS) Market Outlook, By Storage (2016-2026) ($MN)
Table 28 Global Next-Generation Sequencing (NGS) Market Outlook, By LIMS (Laboratory Information Management System) (2016-2026) ($MN)
Table 29 Global Next-Generation Sequencing (NGS) Market Outlook, By Biological Interpretation and Reporting Tools (2016-2026) ($MN)
Table 30 Global Next-Generation Sequencing (NGS) Market Outlook, By Product (2016-2026) ($MN)
Table 31 Global Next-Generation Sequencing (NGS) Market Outlook, By Reagents & Consumables (2016-2026) ($MN)
Table 32 Global Next-Generation Sequencing (NGS) Market Outlook, By Instruments (2016-2026) ($MN)
Table 33 Global Next-Generation Sequencing (NGS) Market Outlook, By Platforms (2016-2026) ($MN)
Table 34 Global Next-Generation Sequencing (NGS) Market Outlook, By Software (2016-2026) ($MN)
Table 35 Global Next-Generation Sequencing (NGS) Market Outlook, By Services (2016-2026) ($MN)
Table 36 Global Next-Generation Sequencing (NGS) Market Outlook, By Technology (2016-2026) ($MN)
Table 37 Global Next-Generation Sequencing (NGS) Market Outlook, By 454 Technology (2016-2026) ($MN)
Table 38 Global Next-Generation Sequencing (NGS) Market Outlook, By DNA Nano Ball Sequencing (2016-2026) ($MN)
Table 39 Global Next-Generation Sequencing (NGS) Market Outlook, By Ion Semiconductor Sequencing (2016-2026) ($MN)
Table 40 Global Next-Generation Sequencing (NGS) Market Outlook, By Ion Torrent Sequencing (2016-2026) ($MN)
Table 41 Global Next-Generation Sequencing (NGS) Market Outlook, By Ion Semiconductor Sequencing (2016-2026) ($MN)
Table 42 Global Next-Generation Sequencing (NGS) Market Outlook, By Massively Parallel Signature Sequencing (MPSS) (2016-2026) ($MN)
Table 43 Global Next-Generation Sequencing (NGS) Market Outlook, By Nanopore Sequencing (2016-2026) ($MN)
Table 44 Global Next-Generation Sequencing (NGS) Market Outlook, By Pyrosequencing (2016-2026) ($MN)
Table 45 Global Next-Generation Sequencing (NGS) Market Outlook, By Reversible Terminator Sequencing (2016-2026) ($MN)
Table 46 Global Next-Generation Sequencing (NGS) Market Outlook, By Sequencing by Ligation (SBL) (2016-2026) ($MN)
Table 47 Global Next-Generation Sequencing (NGS) Market Outlook, By Sequencing By Synthesis (2016-2026) ($MN)
Table 48 Global Next-Generation Sequencing (NGS) Market Outlook, By Sequencing by Synthesis (SBS) (2016-2026) ($MN)
Table 49 Global Next-Generation Sequencing (NGS) Market Outlook, By Single Molecule Real Time (SMRT) Sequencing (2016-2026) ($MN)
Table 50 Global Next-Generation Sequencing (NGS) Market Outlook, By Single-Molecule Real-Time Sequencing (2016-2026) ($MN)
Table 51 Global Next-Generation Sequencing (NGS) Market Outlook, By Supported Oligonucleotide Ligation and Detection (SOLiD) (2016-2026) ($MN)
Table 52 Global Next-Generation Sequencing (NGS) Market Outlook, By Application (2016-2026) ($MN)
Table 53 Global Next-Generation Sequencing (NGS) Market Outlook, By Agrigenomics & Forensics (2016-2026) ($MN)
Table 54 Global Next-Generation Sequencing (NGS) Market Outlook, By Biomarker Discovery and Cancer (2016-2026) ($MN)
Table 55 Global Next-Generation Sequencing (NGS) Market Outlook, By Cardiovascular (2016-2026) ($MN)
Table 56 Global Next-Generation Sequencing (NGS) Market Outlook, By Clinical Investigation (2016-2026) ($MN)
Table 57 Global Next-Generation Sequencing (NGS) Market Outlook, By Consumer Genomics (2016-2026) ($MN)
Table 58 Global Next-Generation Sequencing (NGS) Market Outlook, By Drug Discovery (2016-2026) ($MN)
Table 59 Global Next-Generation Sequencing (NGS) Market Outlook, By Emerging Application (2016-2026) ($MN)
Table 60 Global Next-Generation Sequencing (NGS) Market Outlook, By Forensics (2016-2026) ($MN)
Table 61 Global Next-Generation Sequencing (NGS) Market Outlook, By Genetic Analysis (2016-2026) ($MN)
Table 62 Global Next-Generation Sequencing (NGS) Market Outlook, By Hereditary Disease Detection (2016-2026) ($MN)
Table 63 Global Next-Generation Sequencing (NGS) Market Outlook, By HLA Typing/Immune System Monitoring (2016-2026) ($MN)
Table 64 Global Next-Generation Sequencing (NGS) Market Outlook, By Human Leukocyte Antigen (HLA) Testing (2016-2026) ($MN)
Table 65 Global Next-Generation Sequencing (NGS) Market Outlook, By Infectious Disease Diagnostics (2016-2026) ($MN)
Table 66 Global Next-Generation Sequencing (NGS) Market Outlook, By Life Science (2016-2026) ($MN)
Table 67 Global Next-Generation Sequencing (NGS) Market Outlook, By Metagenomics, Epidemiology & Drug Development (2016-2026) ($MN)
Table 68 Global Next-Generation Sequencing (NGS) Market Outlook, By Oncology (2016-2026) ($MN)
Table 69 Global Next-Generation Sequencing (NGS) Market Outlook, By Pharmaceuticals (2016-2026) ($MN)
Table 70 Global Next-Generation Sequencing (NGS) Market Outlook, By Precision Medicine (2016-2026) ($MN)
Table 71 Global Next-Generation Sequencing (NGS) Market Outlook, By Reproductive Health (2016-2026) ($MN)
Table 72 Global Next-Generation Sequencing (NGS) Market Outlook, By End User (2016-2026) ($MN)
Table 73 Global Next-Generation Sequencing (NGS) Market Outlook, By Academic Institutes & Research Centers (2016-2026) ($MN)
Table 74 Global Next-Generation Sequencing (NGS) Market Outlook, By Agriculture and Animal Research (2016-2026) ($MN)
Table 75 Global Next-Generation Sequencing (NGS) Market Outlook, By Biotech and Pharmaceutical Firms (2016-2026) ($MN)
Table 76 Global Next-Generation Sequencing (NGS) Market Outlook, By Cloud Service Providers (2016-2026) ($MN)
Table 77 Global Next-Generation Sequencing (NGS) Market Outlook, By Contract Research Organization (CROs) (2016-2026) ($MN)
Table 78 Global Next-Generation Sequencing (NGS) Market Outlook, By Diagnostics/Infectious Diseases (2016-2026) ($MN)
Table 79 Global Next-Generation Sequencing (NGS) Market Outlook, By Drug Discovery/Personalized Medicine (2016-2026) ($MN)
Table 80 Global Next-Generation Sequencing (NGS) Market Outlook, By Genetic Screening (2016-2026) ($MN)
Table 81 Global Next-Generation Sequencing (NGS) Market Outlook, By Government Research Institutes (2016-2026) ($MN)
Table 82 Global Next-Generation Sequencing (NGS) Market Outlook, By Hospitals & Clinics (2016-2026) ($MN)
Table 83 Global Next-Generation Sequencing (NGS) Market Outlook, By Pesticides (2016-2026) ($MN)
Table 84 Global Next-Generation Sequencing (NGS) Market Outlook, By Reference Laboratories (2016-2026) ($MN)
Table 85 Global Next-Generation Sequencing (NGS) Market Outlook, By Research Institutions (2016-2026) ($MN)
Table 86 North America Next-Generation Sequencing (NGS) Market Outlook, By Disease (2016-2026) ($MN)
Table 87 North America Next-Generation Sequencing (NGS) Market Outlook, By Service (2016-2026) ($MN)
Table 88 North America Next-Generation Sequencing (NGS) Market Outlook, By Type of Sequencing (2016-2026) ($MN)
Table 89 North America Next-Generation Sequencing (NGS) Market Outlook, By Informatics (2016-2026) ($MN)
Table 90 North America Next-Generation Sequencing (NGS) Market Outlook, By Product (2016-2026) ($MN)
Table 91 North America Next-Generation Sequencing (NGS) Market Outlook, By Technology (2016-2026) ($MN)
Table 92 North America Next-Generation Sequencing (NGS) Market Outlook, By Application (2016-2026) ($MN)
Table 93 North America Next-Generation Sequencing (NGS) Market Outlook, By End User (2016-2026) ($MN)
Table 94 Europe Next-Generation Sequencing (NGS) Market Outlook, By Disease (2016-2026) ($MN)
Table 95 Europe Next-Generation Sequencing (NGS) Market Outlook, By Service (2016-2026) ($MN)
Table 96 Europe Next-Generation Sequencing (NGS) Market Outlook, By Type of Sequencing (2016-2026) ($MN)
Table 97 Europe Next-Generation Sequencing (NGS) Market Outlook, By Informatics (2016-2026) ($MN)
Table 98 Europe Next-Generation Sequencing (NGS) Market Outlook, By Product (2016-2026) ($MN)
Table 99 Europe Next-Generation Sequencing (NGS) Market Outlook, By Technology (2016-2026) ($MN)
Table 100 Europe Next-Generation Sequencing (NGS) Market Outlook, By Application (2016-2026) ($MN)
Table 101 Europe Next-Generation Sequencing (NGS) Market Outlook, By End User (2016-2026) ($MN)
Table 102 Asia Pacific Next-Generation Sequencing (NGS) Market Outlook, By Disease (2016-2026) ($MN)
Table 103 Asia Pacific Next-Generation Sequencing (NGS) Market Outlook, By Service (2016-2026) ($MN)
Table 104 Asia Pacific Next-Generation Sequencing (NGS) Market Outlook, By Type of Sequencing (2016-2026) ($MN)
Table 105 Asia Pacific Next-Generation Sequencing (NGS) Market Outlook, By Informatics (2016-2026) ($MN)
Table 106 Asia Pacific Next-Generation Sequencing (NGS) Market Outlook, By Product (2016-2026) ($MN)
Table 107 Asia Pacific Next-Generation Sequencing (NGS) Market Outlook, By Technology (2016-2026) ($MN)
Table 108 Asia Pacific Next-Generation Sequencing (NGS) Market Outlook, By Application (2016-2026) ($MN)
Table 109 Asia Pacific Next-Generation Sequencing (NGS) Market Outlook, By End User (2016-2026) ($MN)
Table 110 South America Next-Generation Sequencing (NGS) Market Outlook, By Disease (2016-2026) ($MN)
Table 111 South America Next-Generation Sequencing (NGS) Market Outlook, By Service (2016-2026) ($MN)
Table 112 South America Next-Generation Sequencing (NGS) Market Outlook, By Type of Sequencing (2016-2026) ($MN)
Table 113 South America Next-Generation Sequencing (NGS) Market Outlook, By Informatics (2016-2026) ($MN)
Table 114 South America Next-Generation Sequencing (NGS) Market Outlook, By Product (2016-2026) ($MN)
Table 115 South America Next-Generation Sequencing (NGS) Market Outlook, By Technology (2016-2026) ($MN)
Table 116 South America Next-Generation Sequencing (NGS) Market Outlook, By Application (2016-2026) ($MN)
Table 117 South America Next-Generation Sequencing (NGS) Market Outlook, By End User (2016-2026) ($MN)
Table 118 Middle East & Africa Next-Generation Sequencing (NGS) Market Outlook, By Disease (2016-2026) ($MN)
Table 119 Middle East & Africa Next-Generation Sequencing (NGS) Market Outlook, By Service (2016-2026) ($MN)
Table 120 Middle East & Africa Next-Generation Sequencing (NGS) Market Outlook, By Type of Sequencing (2016-2026) ($MN)
Table 121 Middle East & Africa Next-Generation Sequencing (NGS) Market Outlook, By Informatics (2016-2026) ($MN)
Table 122 Middle East & Africa Next-Generation Sequencing (NGS) Market Outlook, By Product (2016-2026) ($MN)
Table 123 Middle East & Africa Next-Generation Sequencing (NGS) Market Outlook, By Technology (2016-2026) ($MN)
Table 124 Middle East & Africa Next-Generation Sequencing (NGS) Market Outlook, By Application (2016-2026) ($MN)
Table 125 Middle East & Africa Next-Generation Sequencing (NGS) Market Outlook, By End User (2016-2026) ($MN)

Note: Product cover images may vary from those shown
3 of 3
  • 10x Genomics
  • Agilent Technologies Inc
  • Beckman Coulter (A Subsidiary of Danaher)
  • Becton, Dickinson and Company
  • BGI
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Genewiz
  • Illumina Inc
  • Macrogen Inc
  • Oxford Nanopore Technologies Ltd
  • Pacific Biosciences of California Inc
  • Perkinelmer Inc
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc
Note: Product cover images may vary from those shown
Adroll
adroll